Can Teladoc Win in a Post-Pandemic World?
When the COVID-19 pandemic started, demand for the services of telemedicine platform provider Teladoc (NYSE: TDOC) surged, turning its stock into one of 2020's biggest winners. However, with people around the world gradually getting back to their pre-pandemic behaviors, can this company continue to grow? In this Fool Live video clip, recorded on Jan. 27, Fool.com contributors Travis Hoium, Rick Munarriz, and Matt Frankel give their thoughts on the future of this healthcare industry disruptor.
Source Fool.com